Aeglea BioTherapeutics In... (AGLE)
NASDAQ: AGLE
· Real-Time Price · USD
12.01
0.75 (6.66%)
At close: Nov 27, 2023, 10:00 PM
Aeglea BioTherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -37.29 | 26.73 | -3.56 | -3.43 | -0.33 | -0.05 | -0.37 | -0.57 | -0.68 | -0.47 | -1.55 | -3.83 | -6.44 | -16.72 | -7.13 |
PEG Ratio | 0.22 | -0.24 | 1.00 | n/a | 0.00 | -0.00 | 0.46 | -0.31 | 0.02 | 0.02 | -0.08 | -9.86 | -0.03 | 0.27 | 0.35 |
PS Ratio | n/a | -8.16K | n/a | n/a | n/a | 62.67 | 138.06 | 255.53 | 284.76 | 66.45 | 111.45 | 85.97 | 373.86 | 33.35 | n/a |
PB Ratio | 13.84 | 13.95 | 3.00 | 1.42 | -0.21 | -0.21 | 0.81 | 0.85 | 0.73 | 0.49 | 2.46 | 3.73 | 5.12 | 3.84 | 4.20 |
P/FCF Ratio | -162.92 | -81.61 | -33.38 | -8.55 | -1.52 | -2.59 | -1.55 | -2.37 | -3.29 | -2.01 | -5.77 | -16.26 | -30.6 | 222.61 | -26.01 |
P/OCF Ratio | -162.92 | -81.61 | -33.38 | -8.55 | -1.52 | -2.59 | -1.55 | -2.37 | -3.29 | -2.01 | -5.78 | -16.26 | -30.77 | 219.40 | -26.6 |
OCF/S Ratio | n/a | 99.93 | n/a | n/a | n/a | -24.19 | -89.06 | -107.98 | -86.6 | -33.08 | -19.28 | -5.29 | -12.15 | 0.15 | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | -0.02 | 0.13 | 0.09 | 0.07 | 0.06 | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 |
Quick Ratio | 8.06 | 11.26 | 7.32 | 19.70 | 4.59 | 1.03 | 3.51 | 4.25 | 4.65 | 6.09 | 4.45 | 4.91 | 5.75 | 6.52 | 4.68 |
Current Ratio | 8.06 | 11.26 | 7.32 | 19.70 | 4.59 | 1.03 | 3.51 | 4.25 | 4.65 | 6.09 | 4.45 | 4.91 | 5.75 | 6.52 | 4.68 |
Asset Turnover | n/a | -0.00 | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.01 | 0.09 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46.74 | -65.12 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.09 | 0.13 | -0.21 | -0.1 | 0.16 | 1.05 | -0.55 | -0.37 | -0.27 | -0.27 | -0.4 | -0.24 | -0.2 | -0.06 | -0.15 |
Return on Assets | -0.08 | 0.11 | -0.16 | -0.09 | -0.19 | -0.89 | -0.35 | -0.26 | -0.2 | -0.21 | -0.29 | -0.19 | -0.16 | -0.05 | -0.11 |
Return on Invested Capital | -0.11 | -0.02 | -0.15 | -0.11 | -0.11 | -10.19 | -0.46 | -0.34 | -0.25 | -0.25 | -0.36 | -0.23 | -0.19 | -0.05 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 1.00 | n/a | n/a | n/a | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | n/a |
Net Profit Margin | n/a | -76.29 | n/a | n/a | n/a | -315.52 | -93.04 | -112.04 | -104.79 | -35.72 | -17.94 | -5.61 | -14.52 | -0.5 | n/a |
Pretax Profit Margin | n/a | -76.38 | n/a | n/a | n/a | -315.51 | -93.22 | -111.81 | -105.99 | -35.7 | -17.94 | -5.6 | -14.5 | -0.49 | n/a |
Operating Profit Margin | n/a | 13.74 | n/a | n/a | n/a | -231.46 | -94.98 | -114.06 | -107.79 | -35.88 | -17.94 | -5.61 | -14.51 | -0.49 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -75.22 | n/a | n/a | n/a | 233.25 | -94.98 | -111.77 | -105.48 | -35.27 | -17.65 | -5.5 | -14.21 | -0.46 | n/a |